Daily non-political popular news in brief.

Genetic analyis for personalizing of treatment of lung and colon cancer, certain sarcomas

Genetic analysis has enabled the personalising of the pharmaceutical treatment of patients with cancer, enhancing thereby therapeutic efficacy and minimising possible toxicity. In concrete, the Biotechnology Laboratory team at the University Hospital (University of Navarra), in close collaboration with the Pharmacogenomics laboratory at the Centre for Applied Medical Research of the same university, undertook these analyses predictive of responses to pharmaceutical drugs in patients with cancer of the lung, the colon and certain types of sarcoma.

Read more »

Keywords: genetic, analyis, personalizing, treatment, lung, colon, cancer, certain, sarcomas, analyi, sarcoma

« Previous | Next »

Similar news on "Genetic analyis for personalizing of treatment of lung and colon cancer, certain sarcomas":

1. Expression patterns of microRNAs appear altered in colon cancer, and associated with poor outcomes
   01-29-2008 · EurekAlert!
   Preliminary research has found an association between certain microRNA expression patterns and poor survival and treatment outcomes for colon cancer, according to a study in the Jan. 30 issue of JAMA.
   Similar news · Read more »
   
2. Gene analysis might explain ethnic differences in sensitivity to chemotherapy in lung cancer
   04-23-2007 · UT Southwestern Medical Center
   Analysis of three genetic mechanisms that cause non-small cell lung cancer might explain why East Asians respond better than other ethnic groups to a certain type of chemotherapy, a team led by UT Southwestern Medical Center researchers has found.
   Similar news · Read more »
   
3. Jefferson researchers show chemotherapy and radiation together extend lung cancer patients' lives
   11-09-2007 · EurekAlert!
   Chemotherapy given at the same time as radiation therapy can help patients with a certain type of lung cancer live nearly 50 percent longer than they might have otherwise if the same treatment was given differently, according to an international team’s analysis of several trial results.
   Similar news · Read more »
   
4. Pre-treatment blood test could guide lung cancer therapy
   06-05-2007 · EurekAlert!
   A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has developed a new pre-treatment blood test that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies (Iressa, Tarceva). The mass spectrometry-based test, described in the June 6 Journal of the National Cancer Institute, may allow physicians to select the most beneficial therapy for each lung cancer patient, a step forward in the era of personalized medicine.
   Similar news · Read more »
   
5. Substance in tree bark could lead to new lung-cancer treatment
   06-25-2007 · UT Southwestern Medical Center
   Researchers at UT Southwestern Medical Center have determined how a substance derived from the bark of the South American lapacho tree kills certain kinds of cancer cells, findings that also suggest a novel treatment for the most common type of lung cancer.
   Similar news · Read more »
   
6. Gene analysis might explain ethnic differences in sensitivity to chemotherapy in lung cancer
   04-23-2007 · EurekAlert!
   Analysis of three genetic mechanisms that cause nonsmall cell lung cancer might explain why East Asians respond better than other ethnic groups to a certain type of chemotherapy, a team led by UT Southwestern Medical Center researchers has found.
   Similar news · Read more »
   
7. Novel MS drug shows promise in 2 lethal leukemias
   08-28-2007 · EurekAlert!
   A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia. The laboratory and animal study focused on the drug, called fingolimod. Researchers said it might help patients with advanced chronic myelogenous leukemia or acute lymphocytic leukemia, and whose cancer cells show a particular genetic change called the Philadelphia chromosome.
   Similar news · Read more »
   
8. Black Americans' beliefs may hamper lung cancer prevention and care
   06-02-2007 · EurekAlert!
   Blacks in the United States are less certain than whites about recommendations to prevent lung cancer and are more fearful of having symptoms evaluated -- beliefs that may keep them from seeking timely treatment for the disease, researchers from Dana-Farber Cancer Institute reported at the American Society of Clinical Oncology's annual meeting in Chicago.
   Similar news · Read more »
   
9. Certain types of cancer becoming more common, while rates of others decreasing
   12-15-2006 · EurekAlert!
   Nation-wide statistics indicate that while some types of cancer are occurring less frequently, the rates of others are still surging upward. According to a new study published in Annals of the New York Academy of Sciences, incidence of skin cancer is climbing in both sexes -- more men are facing prostate cancer, while more women are diagnosed with breast cancer. Cancers showing a decrease in incidence in both sexes include lung, stomach and colon cancers.
   Similar news · Read more »
   
10. CTRC enrolls first patients in Novel Phase II study for sarcoma -- Living virus destroys cancer cell
    07-24-2007 · EurekAlert!
    The Cancer Therapy & Research Center Institute for Drug Development, in collaboration with Oncolytics Biotech Inc., a biotechnology company, has enrolled the first two patients in a new Phase II clinical study for patients with various types of sarcomas that have metastasized to the lung. The novel anti-cancer therapy, REOLYSIN, is a living virus, not a chemotherapy drug, that is toxic to cancer cells but not harmful to normal cells.
    Similar news · Read more »